67 results
424B3
MOTS
Motus GI Holdings Inc
2 Apr 24
Prospectus supplement
4:40pm
such as labor, freight and materials;
our ability to project in the short term the hospital medical device environment considering the global pandemic
8-K
EX-99.1
MOTS
Motus GI Holdings Inc
18 Mar 24
Motus GI Reports Fourth Quarter and Full Year 2023 Financial Results
4:05pm
impact of the COVID-19 pandemic, risks inherent in the development and commercialization of potential products, possible or assumed future results
424B3
7k3azyhedf6c
9 Jun 23
Prospectus supplement
4:15pm
8-K
EX-99.1
ttwe4a3ma2mrb5
22 May 23
Motus GI Announces $3.5 Million Private Placement
9:14am
8-K
EX-99.1
f16yohyvnmz7bs pvb
17 May 23
Motus GI Completes First Clinical Evaluation of New Pure-Vu® Gastro
8:35am
8-K
EX-99.1
b9fou8uv
11 May 23
Regulation FD Disclosure
7:05am
8-K
EX-99.1
smnv96eo d7qr
10 May 23
Motus GI Reports First Quarter 2023 Financial Results
4:05pm
8-K
EX-99.1
l3upnepzy39cn2tn kb
31 Mar 23
Motus GI Reports Fourth Quarter and Full Year 2022 Financial Results
4:05pm
8-K
EX-99.1
9p805bq9tgu5ky udmt
21 Dec 22
Motus GI Announces Improvement of Pure-Vu® EVS System for Use in Upper Gastrointestinal (GI) Bleeding Procedures Following Successful Pre-Clinical Tests
8:12am
8-K
EX-99.1
a6uah0rb825zagcmf5y1
14 Nov 22
Motus GI Reports Third Quarter 2022 Financial Results
4:14pm
8-K
EX-99.1
p8w9e2
24 Oct 22
Motus GI Announces Positive Clinical Data for Pure-Vu EVS in Three Poster
8:40am
8-K
EX-99.1
l7sjr2ngfgn6pcgz2k
6 Oct 22
Motus GI Granted a U.S. Patent for Prepless Colonoscopy Methods
9:15am
8-K
EX-99.1
3cn 8l4cu38h
29 Sep 22
Regulation FD Disclosure
9:15am